mofarotene
Small moleculeexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- Retinoid receptorMODULATOR
Retinoid receptor modulator
- Retinoic acid receptor RXR-beta (RXRB) ↗
- Retinoic acid receptor gamma (RARG) ↗
- Retinoic acid receptor RXR-gamma (RXRG) ↗
- Retinoic acid receptor beta (RARB) ↗
- Retinoic acid receptor alpha (RARA) ↗
- Retinoic acid receptor RXR-alpha (RXRA) ↗
- Retinoic acid receptor alpha
- Retinoic acid receptor gamma
- Retinoid X receptor gamma
- Retinoic acid receptor beta
- Retinoid X receptor alpha
- Retinoid X receptor beta
- Retinoic acid receptor
- Retinoid X receptor
- Retinoid X receptor gamma/retinoic acid receptor alpha
- Retinoic acid receptor alpha/Retinoid X receptor alpha
- Retinoic acid receptor RXR-alpha/Retinoic acid receptor beta
- Retinoic acid receptor RXR-alpha/gamma
Chemistry & pharmacology
Loading structure…
SMILES
C/C(=C\c1ccc(OCCN2CCOCC2)cc1)c1ccc2c(c1)C(C)(C)CCC2(C)C- Mol. weight
- 433.64 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL146506 ↗
Also known as
- 4-((2-(p-((e)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)propenyl)phenoxy)ethyl))morpholine
- arotinoid ro 40-8757
- mofarotene
- mofarotene
- mofarotene
- ro 40-8757
- ro-408757
- ro-408757
- ro-40-8757